oncotype login
Searching for oncotype login? Use official links below to sign-in to your account.
If there are any problems with oncotype login, check if password and username is written correctly. Also, you can contact with customer support and ask them for help. If you don't remember you personal data, use button "Forgot Password". If you don't have an account yet, please create a new one by clicking sign up button/link.
online.genomichealth.com
- https://online.genomichealth.com/Login.aspx
- We would like to show you a description here but the site won’t allow us.
- Status:Page Online
How to Order | Oncotype DX Breast Recurrence Score ...
- https://www.oncotypeiq.com/en-GB/breast-cancer/healthcare-professionals/oncotype-dx-breast-recurrence-score/how-to-order-a-test
- The Oncotype DX invasive breast cancer results are typically reported within 7 - 10 days after the sample is received. Reports can be delivered by fax or secure online transfer to the treating physician, submitting pathologist and/or other authorized healthcare providers.
- Status:Page Online
About the Oncotype DX Breast Recurrence Score® | Oncotype IQ®
- https://www.oncotypeiq.com/en-GB/breast-cancer/patients-and-carers/stage-i-iiia-invasive/about-the-test
- In the US and certain other jurisdictions, Genomic Health, Oncotype DX, Oncotype IQ, Recurrence Score, Oncotype DX Breast Recurrence Score, Oncotype DX Colon Recurrence Score, and Oncotype DX Genomic Prostate Score are registered trademarks, and "Making cancer care smarter," GPS, and AR-V7 Nucleus Detect are pending registered trademarks, of Genomic Health, Inc.
- Status:Page Online
Smarter Cancer Care - Genomic Testing | Oncotype IQ®
- https://www.oncotypeiq.com/en-GB
- In the US and certain other jurisdictions, Genomic Health, Oncotype DX, Oncotype IQ, Recurrence Score, Oncotype DX Breast Recurrence Score, Oncotype DX Colon Recurrence Score, and Oncotype DX Genomic Prostate Score are registered trademarks, and "Making cancer care smarter," GPS, and AR-V7 Nucleus Detect are pending registered trademarks, of Genomic Health, Inc.
- Status:Page Online
Oncotype DX - Breast Cancer Now
- https://breastcancernow.org/information-support/facing-breast-cancer/diagnosed-breast-cancer/oncotype-dx
- Oncotype DX is a test that predicts how likely breast cancer is to come back after surgery and the likely benefit of having chemotherapy. The test gives a score between 0 and 100, and people who score above a certain number are more likely to be offered chemotherapy ...
- Status:Page Online
Oncotype DX for Breast Cancer | Genomic Health UK, Ltd.
- https://www.genomichealth.com/en-GB/oncotype_iq_products/oncotype_dx/oncotype_dx_breast_cancer
- Oncotype DX ® for Early-Stage, Invasive Breast Cancer. The company's lead product, the Oncotype DX breast cancer test, is the only multigene expression test commercially available that has clinical evidence validating its ability to predict the likelihood of chemotherapy benefit as well as recurrence in early-stage invasive breast cancer.
- Status:Page Online
Making cancer care smarter with Oncotype DX tests ...
- https://www.oncotypeiq.com/en-US
- The only genomic test proven to predict a patient’s individual benefit from chemotherapy. For patients with early-stage, ER-positive, HER2-negative, node negative, and node-positive (1-3) breast cancer, the Oncotype DX Breast Recurrence Score quantifies the risk of distant recurrence and the likelihood of chemotherapy benefit.
- Status:Page Online
Oncotype DX for Breast Cancer | Genomic Health, Inc.
- https://www.genomichealth.com/en-US/oncotype_iq_products/oncotype_dx/oncotype_dx_breast_cancer
- Tailoring Treatment for Individual Patients with Early-Stage Breast Cancer. Oncotype DX for Early-Stage, Invasive Breast Cancer. The Oncotype DX breast cancer test examines the activity of 21 genes in a patient’s breast tumor tissue to provide personalized information for tailoring treatment based on the biology of their individual disease.
- Status:Page Online
Report Your Problem